Evidence map›Paper›PMID 38769440›Full record

ArticleScientific reports2024

Exploring fluoropolymers for fabrication of femtoliter chamber arrays used in digital bioanalysis.

Jun Ando, Kazue Murai, Makiko Mori, Tomoe Michiyuki, Tatsuya Iida, Asami Makino, Hajime Shinoda, Rikiya Watanabe

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jun AndoMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan. ando@riken.jp.
Kazue MuraiMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Makiko MoriMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Tomoe MichiyukiMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Tatsuya IidaMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Asami MakinoMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Hajime ShinodaMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan.
Rikiya WatanabeMolecular Physiology Laboratory, Cluster for Pioneering Research, RIKEN, Saitama, Japan. rikiya.watanabe@riken.jp.

Funding

Japan Agency for Medical Research and Development JP22he0422018Japan Science and Technology Agency JPMJCR19H5Japan Society for the Promotion of Science 20H05931Japan Society for the Promotion of Science 22H01996
6 · The paper itself

Abstract

The global supply of fluoropolymers and fluorinated solvents is decreasing due to environmental concerns regarding polyfluoroalkyl substances. CYTOP has been used for decades primarily as a component of a femtoliter chamber array for digital bioanalysis; however, its supply has recently become scarce, increasing the urgency of fabricating a femtoliter chamber array using alternative materials. In this study, we investigated the feasibility of fabricating a femtoliter chamber array using four types of fluoropolymers in stable supply as candidate substitutes and verified their applicability for digital bioanalysis. Among these candidates, Fluorine Sealant emerged as a viable option for fabricating femtoliter chamber arrays using a conventional photolithography process. To validate its efficacy, we performed various digital bioanalysis using FP-A-based chamber arrays with model enzymes such as CRISPR-Cas, horseradish peroxidase, and β-galactosidase. The results demonstrated the similar performance to that of CYTOP, highlighting the broader utility of FP-A in digital bioanalysis. Our findings underscore the potential of FP-A to enhance the versatility of digital bioanalysis and foster the ongoing advancement of innovative diagnostic technologies.

Indexed as

Polymersbeta-GalactosidaseHorseradish Peroxidasebeta-GalactosidaseHorseradish PeroxidasePolymers

Identifiers

PMID38769440
PMCPMC11106263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.